These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31750274)

  • 1. Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma.
    Kiyokawa J; Wakimoto H
    Oncolytic Virother; 2019; 8():27-37. PubMed ID: 31750274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma.
    Lang FF; Conrad C; Gomez-Manzano C; Yung WKA; Sawaya R; Weinberg JS; Prabhu SS; Rao G; Fuller GN; Aldape KD; Gumin J; Vence LM; Wistuba I; Rodriguez-Canales J; Villalobos PA; Dirven CMF; Tejada S; Valle RD; Alonso MM; Ewald B; Peterkin JJ; Tufaro F; Fueyo J
    J Clin Oncol; 2018 May; 36(14):1419-1427. PubMed ID: 29432077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic viruses as treatment for adult and pediatric high-grade gliomas: On the way to clinical success.
    Hervás-Corpión I; Alonso MM
    Int Rev Cell Mol Biol; 2023; 379():169-188. PubMed ID: 37541723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta-24 adenoviral therapy for glioblastoma: evolution from the bench to bedside and future considerations.
    Ene CI; Fueyo J; Lang FF
    Neurosurg Focus; 2021 Feb; 50(2):E6. PubMed ID: 33524949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNX-2401: an investigational drug for the treatment of recurrent glioblastoma.
    Philbrick B; Adamson DC
    Expert Opin Investig Drugs; 2019 Dec; 28(12):1041-1049. PubMed ID: 31726894
    [No Abstract]   [Full Text] [Related]  

  • 6. Double-modified oncolytic adenovirus armed with a recombinant interferon-like gene enhanced abscopal effects against malignant glioma.
    Jiang S; Chai HH; Fang XL; Xu HS; Li TW; Tang QS; Gu JF; Zhang KJ; Liu XY; Shi ZF; Cao XP; Wu ZY; Zhou LF
    Neurooncol Adv; 2023; 5(1):vdad117. PubMed ID: 37841695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers.
    Wakayama M; Abei M; Kawashima R; Seo E; Fukuda K; Ugai H; Murata T; Tanaka N; Hyodo I; Hamada H; Yokoyama KK
    Clin Cancer Res; 2007 May; 13(10):3043-50. PubMed ID: 17505007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNX-2401, an Oncolytic Virus, for the Treatment of Newly Diagnosed Diffuse Intrinsic Pontine Gliomas: A Case Report.
    Tejada S; Díez-Valle R; Domínguez PD; Patiño-García A; González-Huarriz M; Fueyo J; Gomez-Manzano C; Idoate MA; Peterkin J; Alonso MM
    Front Oncol; 2018; 8():61. PubMed ID: 29594041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway.
    Fueyo J; Alemany R; Gomez-Manzano C; Fuller GN; Khan A; Conrad CA; Liu TJ; Jiang H; Lemoine MG; Suzuki K; Sawaya R; Curiel DT; Yung WK; Lang FF
    J Natl Cancer Inst; 2003 May; 95(9):652-60. PubMed ID: 12734316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Therapy for High Grade Glioma: The Clinical Experience.
    Varela ML; Comba A; Faisal SM; Argento A; Franson A; Barissi MN; Sachdev S; Castro MG; Lowenstein PR
    Expert Opin Biol Ther; 2023 Feb; 23(2):145-161. PubMed ID: 36510843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tropism-transformed Oncolytic Adenovirus with Dual Capsid Modifications for enhanced Glioblastoma Therapy.
    Wang L; Liu W; Li Z; Wang X; Feng X; Wang Z; Wu J; Zhang H; Wu H; Kong W; Yu B; Yu X
    J Cancer; 2020; 11(19):5713-5726. PubMed ID: 32913465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy.
    Lamfers ML; Grill J; Dirven CM; Van Beusechem VW; Geoerger B; Van Den Berg J; Alemany R; Fueyo J; Curiel DT; Vassal G; Pinedo HM; Vandertop WP; Gerritsen WR
    Cancer Res; 2002 Oct; 62(20):5736-42. PubMed ID: 12384532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic herpes simplex virus therapy for malignant glioma: current approaches to successful clinical application.
    Hua L; Wakimoto H
    Expert Opin Biol Ther; 2019 Aug; 19(8):845-854. PubMed ID: 31046478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic adenovirus Delta-24-RGD induces a widespread glioma proteotype remodeling during autophagy.
    González-Morales A; Zabaleta A; García-Moure M; Alonso MM; Fernández-Irigoyen J; Santamaría E
    J Proteomics; 2019 Mar; 194():168-178. PubMed ID: 30503830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
    Wang H; Wei F; Li H; Ji X; Li S; Chen X
    Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials using oncolytic viral therapy to treat adult glioblastoma: a progress report.
    Lu VM; Shah AH; Vallejo FA; Eichberg DG; Luther EM; Shah SS; Komotar RJ; Ivan ME
    Neurosurg Focus; 2021 Feb; 50(2):E3. PubMed ID: 33524946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue inhibitor of metalloproteinase-3 expression from an oncolytic adenovirus inhibits matrix metalloproteinase activity in vivo without affecting antitumor efficacy in malignant glioma.
    Lamfers ML; Gianni D; Tung CH; Idema S; Schagen FH; Carette JE; Quax PH; Van Beusechem VW; Vandertop WP; Dirven CM; Chiocca EA; Gerritsen WR
    Cancer Res; 2005 Oct; 65(20):9398-405. PubMed ID: 16230403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic concentrations of anti-epileptic drugs do not inhibit the activity of the oncolytic adenovirus Delta24-RGD in malignant glioma.
    de Jonge J; Berghauser Pont LM; Idema S; Kloezeman JJ; Noske D; Dirven CM; Lamfers ML
    J Gene Med; 2013; 15(3-4):134-41. PubMed ID: 23606319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial and temporal proteome dynamics of glioma cells during oncolytic adenovirus Delta-24-RGD infection.
    González-Morales A; Zabaleta A; Guruceaga E; Alonso MM; García-Moure M; Fernández-Irigoyen J; Santamaría E
    Oncotarget; 2018 Jul; 9(57):31045-31065. PubMed ID: 30123426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically modified adenoviruses against gliomas: from bench to bedside.
    Gomez-Manzano C; Yung WK; Alemany R; Fueyo J
    Neurology; 2004 Aug; 63(3):418-26. PubMed ID: 15304571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.